Literature DB >> 21790583

Computational prediction of MHC II-antigen binding supports divergent allele advantage and explains trans-species polymorphism.

Tobias L Lenz1.   

Abstract

The major histocompatibility complex (MHC), coding for antigen presenting molecules of the adaptive immune system, represents one of the most polymorphic regions in the vertebrate genome. The exceptional polymorphism, which is potentially maintained by balancing selection under host-parasite coevolution, comprises excessive sequence divergence among alleles as well as ancient allelic lineages that predate species divergence (trans-species polymorphism). Here, the mechanisms that are proposed to maintain such sequence divergence and ancient lineages are investigated. Established computational antigen-binding prediction algorithms, which are based on empirical databases, are employed to determine the overlap in bound antigens among individual MHC class IIB alleles. The results show that genetically more divergent allele pairs experience less overlap and thus present a broader range of potential antigens. These findings support the divergent allele advantage hypothesis and furthermore suggest an evolutionary advantage explaining the maintenance of divergent allelic lineages, that is, trans-species polymorphism. In addressing a quantitative rather than qualitative aspect of MHC alleles, these insights highlight a new direction for future research on MHC evolution.
© 2011 The Author(s). Evolution© 2011 The Society for the Study of Evolution.

Mesh:

Substances:

Year:  2011        PMID: 21790583     DOI: 10.1111/j.1558-5646.2011.01288.x

Source DB:  PubMed          Journal:  Evolution        ISSN: 0014-3820            Impact factor:   3.694


  39 in total

1.  Uterine selection for immunocompetent offspring.

Authors:  Tobias L Lenz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-14       Impact factor: 11.205

2.  MHC structuring and divergent allele advantage in a urodele amphibian: a hierarchical multi-scale approach.

Authors:  Lorenzo Talarico; Wiesław Babik; Silvio Marta; Venusta Pietrocini; Marco Mattoccia
Journal:  Heredity (Edinb)       Date:  2019-04-29       Impact factor: 3.821

3.  Odour-based discrimination of similarity at the major histocompatibility complex in birds.

Authors:  Sarah Leclaire; Maria Strandh; Jérôme Mardon; Helena Westerdahl; Francesco Bonadonna
Journal:  Proc Biol Sci       Date:  2017-01-11       Impact factor: 5.349

4.  The functional importance of sequence versus expression variability of MHC alleles in parasite resistance.

Authors:  Jan Axtner; Simone Sommer
Journal:  Genetica       Date:  2012-11-24       Impact factor: 1.082

5.  Lack of evidence for selection favouring MHC haplotypes that combine high functional diversity.

Authors:  Arnaud Gaigher; Alexandre Roulin; Walid H Gharib; Pierre Taberlet; Reto Burri; Luca Fumagalli
Journal:  Heredity (Edinb)       Date:  2018-01-24       Impact factor: 3.821

Review 6.  Host-parasite co-evolution and its genomic signature.

Authors:  Dieter Ebert; Peter D Fields
Journal:  Nat Rev Genet       Date:  2020-08-28       Impact factor: 53.242

7.  Adaptive value of novel MHC immune gene variants.

Authors:  Tobias L Lenz
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-31       Impact factor: 11.205

8.  Mating preferences can drive expansion or contraction of major histocompatibility complex gene family.

Authors:  Piotr Bentkowski; Jacek Radwan
Journal:  Proc Biol Sci       Date:  2020-02-26       Impact factor: 5.349

9.  Divergent allele advantage at MHC-DRB through direct and maternal genotypic effects and its consequences for allele pool composition and mating.

Authors:  Tobias L Lenz; Birte Mueller; Fritz Trillmich; Jochen B W Wolf
Journal:  Proc Biol Sci       Date:  2013-07-07       Impact factor: 5.349

10.  Mhc supertypes confer both qualitative and quantitative resistance to avian malaria infections in a wild bird population.

Authors:  Irem Sepil; Shelly Lachish; Amy E Hinks; Ben C Sheldon
Journal:  Proc Biol Sci       Date:  2013-03-20       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.